Best TWAS P=5.5e-25 · Best GWAS P=5.36e-26 conditioned to 4.4e-05
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Cells EBV-transformed lymphocytes | MTHFR | 0.33 | 0.12 | lasso | 6 | 0.09 | 7.9e-04 | 6.62 | 6.6 | 3.6e-11 | 0.80 | 0.33 | 0.29 | FALSE |
2 | GTEx | Cells Transformed fibroblasts | CLCN6 | 0.08 | 0.02 | enet | 17 | 0.05 | 1.6e-04 | 10.54 | 8.0 | 1.3e-15 | 0.75 | 0.01 | 0.99 | FALSE |
3 | GTEx | Cells Transformed fibroblasts | MTHFR | 0.13 | 0.03 | enet | 30 | 0.05 | 6.8e-05 | 7.04 | 7.8 | 5.7e-15 | 0.57 | 0.04 | 0.93 | FALSE |
4 | GTEx | Skin Not Sun Exposed Suprapubic | CLCN6 | 0.12 | 0.03 | lasso | 3 | 0.04 | 3.3e-03 | 5.61 | 8.8 | 1.7e-18 | 0.83 | 0.02 | 0.94 | FALSE |
5 | GTEx | Skin Sun Exposed Lower leg | CLCN6 | 0.08 | 0.00 | lasso | 3 | 0.01 | 7.9e-02 | 3.51 | 6.0 | 1.7e-09 | 0.67 | 0.03 | 0.73 | FALSE |
6 | GTEx | Spleen | CLCN6 | 0.21 | 0.10 | lasso | 3 | 0.06 | 1.3e-02 | 6.74 | 8.0 | 9.6e-16 | 0.86 | 0.04 | 0.70 | FALSE |
7 | METSIM | Adipose | CLCN6 | 0.09 | 0.04 | blup | 480 | 0.06 | 1.6e-09 | 4.78 | 6.4 | 1.8e-10 | 0.65 | 0.06 | 0.94 | FALSE |
8 | METSIM | Adipose | DRAXIN | 0.09 | 0.01 | enet | 21 | 0.04 | 1.6e-06 | 0.95 | -5.3 | 9.8e-08 | -0.51 | 0.03 | 0.92 | FALSE |
9 | NTR | Blood | AGTRAP | 0.02 | 0.00 | bslmm | 484 | 0.00 | 5.2e-02 | -0.37 | -5.3 | 1.3e-07 | -0.38 | 0.05 | 0.06 | FALSE |
10 | NTR | Blood | CLCN6 | 0.01 | 0.01 | lasso | 2 | 0.01 | 3.0e-04 | 6.77 | 5.4 | 6.7e-08 | 0.78 | 0.38 | 0.53 | TRUE |
11 | NTR | Blood | MTHFR | 0.09 | 0.07 | enet | 17 | 0.10 | 4.4e-31 | 3.51 | 7.0 | 2.1e-12 | 0.66 | 1.00 | 0.00 | FALSE |
12 | YFS | Blood | MTHFR | 0.50 | 0.49 | enet | 40 | 0.62 | 5.5e-264 | 3.51 | 5.6 | 1.8e-08 | 0.52 | 1.00 | 0.00 | FALSE |
13 | The Cancer Genome Atlas | Breast Invasive Carcinoma | CLCN6 | 0.06 | 0.06 | blup | 104 | 0.06 | 5.0e-12 | 7.37 | 10.2 | 1.4e-24 | 0.75 | 0.22 | 0.78 | FALSE |
14 | The Cancer Genome Atlas | Colon Adenocarcinoma | CLCN6 | 0.14 | 0.05 | blup | 104 | 0.09 | 1.2e-05 | 10.31 | 7.2 | 5.2e-13 | 0.81 | 0.01 | 0.98 | FALSE |
15 | The Cancer Genome Atlas | Colon Adenocarcinoma | MTHFR | 0.07 | 0.01 | blup | 92 | 0.04 | 2.9e-03 | 0.39 | 6.9 | 4.3e-12 | 0.76 | 0.04 | 0.47 | FALSE |
16 | The Cancer Genome Atlas | Colon Adenocarcinoma | NPPA | 0.06 | 0.01 | lasso | 5 | 0.01 | 1.3e-01 | 3.47 | -5.4 | 6.1e-08 | -0.34 | 0.04 | 0.24 | FALSE |
17 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | CLCN6 | 0.04 | 0.06 | lasso | 2 | 0.05 | 1.1e-06 | 7.37 | 8.4 | 3.5e-17 | 0.69 | 0.10 | 0.89 | FALSE |
18 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | CLCN6 | 0.05 | 0.05 | lasso | 6 | 0.05 | 9.2e-07 | 3.51 | 6.3 | 3.3e-10 | 0.51 | 0.50 | 0.47 | FALSE |
19 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | CLCN6 | 0.07 | 0.00 | blup | 104 | 0.03 | 7.9e-03 | -2.46 | 5.9 | 3.0e-09 | 0.60 | 0.06 | 0.28 | FALSE |
20 | The Cancer Genome Atlas | Lung Adenocarcinoma | CLCN6 | 0.06 | 0.04 | blup | 104 | 0.04 | 5.2e-06 | 10.54 | 10.3 | 5.5e-25 | 0.91 | 0.01 | 0.99 | TRUE |
21 | The Cancer Genome Atlas | Prostate Adenocarcinoma | CLCN6 | 0.10 | 0.07 | blup | 104 | 0.07 | 3.9e-08 | 7.84 | 10.0 | 1.1e-23 | 0.59 | 0.20 | 0.80 | FALSE |
22 | The Cancer Genome Atlas | Stomach Adenocarcinoma | CLCN6 | 0.07 | 0.04 | blup | 104 | 0.05 | 2.4e-04 | 10.31 | 9.6 | 6.1e-22 | 0.94 | 0.01 | 0.98 | FALSE |
23 | The Cancer Genome Atlas | Stomach Adenocarcinoma | NPPA | 0.06 | 0.03 | enet | 4 | 0.04 | 7.6e-04 | 7.84 | -6.1 | 8.3e-10 | -0.45 | 0.11 | 0.15 | FALSE |
24 | The Cancer Genome Atlas | Thyroid Carcinoma | CLCN6 | 0.08 | 0.02 | blup | 104 | 0.05 | 2.5e-05 | 4.88 | 7.3 | 2.8e-13 | 0.64 | 0.15 | 0.84 | FALSE |